Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Miltenyi Biotec (Germany)

InstitutionResearch output, impact & collaborations

Miltenyi Biotec (Germany) is a research organisation in Cologne, DE. OpenAlex records 1,259 works and 159,222 citations for it. 835 researchers list it as their most recent affiliation.

1,259
Works
159,222
Citations
835
Researchers
26
Avg h-index

How has Miltenyi Biotec (Germany)'s publication output changed over time?

ScholarIQpublication output · 2006–2020

Output grew100% over the shown period — from 1 works in 2006 to 2 in 2020.

1
1
1
1
1
2
2
2
20062012201320142016201720182020

Who are the most-cited researchers behind Miltenyi Biotec (Germany)?

ScholarIQtop researchers by citations
1
Jörg Mahlich · Health Systems, Economic Evaluations, Quality of Life
163 works1,837 citations

What are the most-cited papers on Miltenyi Biotec (Germany)?

ScholarIQmost cited works
Understanding the global measurement of willingness to pay in health
Jean A. McDougall, Wesley Furnback, Bruce C. M. Wang, Jörg Mahlich
S4210225199. 2020163 CitationsOPEN ACCESS
Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
Jörg Mahlich, Rosarin Sruamsiri
Patient Preference and Adherence. 201651 CitationsOPEN ACCESS
Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
Rosarin Sruamsiri, Kosuke Iwasaki, Wentao Tang, Jörg Mahlich
S151902004. 201850 CitationsOPEN ACCESS
Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study
Jörg Mahlich, Sunny Tsukazawa, Frank Wiegand
Drugs - Real World Outcomes. 201748 CitationsOPEN ACCESS
Cultural beliefs, utility values, and health technology assessment
Jörg Mahlich, Piyameth Dilokthornsakul, Rosarin Sruamsiri, Nathorn Chaiyakunapruk
Cost Effectiveness and Resource Allocation. 201845 CitationsOPEN ACCESS

How much of the research on Miltenyi Biotec (Germany) is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
82%
Green
9%
Hybrid
0%
Bronze
9%
Closed
0%

Related on ScholarIQ

CAR-T cell therapy research
Top Topic
Immune Cell Function and Interaction
Top Topic
T-cell and B-cell Immunology
Top Topic
Immunotherapy and Immune Responses
Top Topic
Monoclonal and Polyclonal Antibodies Research
Top Topic
Viral Infectious Diseases and Gene Expression in Insects
Top Topic
470M+ articles · free account